Dataset from A Double-blind, Placebo-controlled Study, Followed by an Open-label Extension Study Evaluating the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic Disorder

The purpose of this study is to evaluate the efficacy of risperidone compared with placebo in children and adolescents with irritability associated with autistic disorder.

本研究旨在评估利培酮（risperidone）与安慰剂（placebo）相比，在伴发易怒症状的儿童及青少年孤独症障碍（autistic disorder）患者中的疗效。